1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > MediPoint: Spinal Fusion - EU Analysis and Market Forecasts

MediPoint: Spinal Fusion - EU Analysis and Market Forecasts

Summary

Spinal fusion surgery is a well-established procedure that has been performed since the early 1900s. The procedure has benefited immensely from its long history of use, investments in advancing technologies, and its clinical success in a growing variety of spinal conditions. These traits have led spinal fusion surgery to become one of the most frequently performed surgeries in the US, which is undoubtedly, the largest geographic market for this procedure. Given the global phenomenon of an aging society and the associated increasing incidences of degenerative spinal conditions, the spinal fusion market is expected to remain strong over the forecast period.

The specific anatomical regions being operated on are covered, including cervical and thoracolumbar. Furthermore, this report analyzes the adoption of these implantables in single-, double-, and triple-level surgeries, creating the most comprehensive and accurate market valuations and coverage. The report analyzes how these surgical trends vary in the major markets in European Union including France, Germany, Italy, Spain, and the United Kingdom (UK).

Scope

- An overview of Spinal fusion, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized EU Spinal fusion market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020.
- Investigation of current and future market competition for Spinal fusion.
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the Spinal fusion sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as doctors

Reasons to buy

- Understand the trends shaping and driving EU Spinal fusion market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in EU Spinal fusion market through 2018.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- What’s the next big thing in EU Spinal fusion market landscape? Identify, understand and capitalize.

Table Of Contents

MediPoint: Spinal Fusion - EU Analysis and Market Forecasts
1 Table of Contents

2 Introduction 13
2.1 Overview 13
2.2 Catalyst 13
3 Industry Overview 15
3.1 Indications 15
3.2 Types of Devices 17
3.2.1 Spinal Plating Systems 17
3.2.2 Interbody Cages 18
3.2.3 Pedicle Screw Systems 19
3.3 Procedure Trends 20
3.4 Market Access 26
3.4.1 Regulation 26
3.4.2 Adoption 28
3.4.3 Reimbursement Trends 29
4 Market Dynamics: Mergers, Acquisitions and Key Partnerships 34
4.1 Overview 34
4.1.1 Amedica Corporation Acquires US Spine 35
4.1.2 Alphatec Spine Acquires Scient'x Group 35
4.1.3 Biomet Acquires Lanx, Inc. 35
4.1.4 Globus Medical Acquires Facet Solutions 35
4.1.5 Integra LifeSciences Holdings Corporation Acquires SeaSpine, Inc. 36
4.1.6 Medtronic Acquires Advanced Medical Technologies and China's Kanghui 36
4.1.7 Nuvasive Acquires ANC 36
4.1.8 TranS1 Inc. Acquires Baxano Inc. 36
4.2 Economic Impact 37
5 Unmet Needs 40
5.1 Improved Reimbursement Coverage for Minimally Invasive Surgical Procedures 40
5.2 Lack of Definitive Methods to Determine Fusion Performance 41
5.3 Technological Developments in the Use of Long Fusions 41
5.4 Research and Development into Fusion Enhancers 43
5.5 Improve Osseointegration of Bone and Screw Interface 44
6 Market Opportunity Analysis 46
6.1 Develop Signature Minimally Invasive Technique 46
6.2 Market Minimally Invasive Training Opportunities to Fellowship Programs 47
6.3 Increased Collaboration of Medical Device Implants and Biologics 48
6.4 Develop a Device that Provides Real-Time Fusion Updates 49
6.5 Increased Customization of Spinal Implants to Patient Anatomy 49
7 Market Drivers 51
7.1 Aging Patient Populations 51
7.2 Growth in the Spinal Stenosis Indication 53
7.3 Gold Standard for Treating Spinal Instability and Degenerative Conditions 55
7.4 Treatment for a Variety of Indications 55
7.5 Preference for Minimally Invasive Techniques 56
7.6 Advances in Navigation Technology 58
8 Market Barriers 59
8.1 Incidence of Adjacent Segment Disease 59
8.2 Performance of Non-Fusion Technologies 59
8.3 Increased Scrutiny over Spinal Fusion's Necessity in the US 61
8.4 Restricted Reimbursement from Private Payers 62
8.5 Performance in Treating Axial Back Pain 63
9 Pipeline Assessment 64
10 Clinical Trial Analysis 67
11 Current and Future Players 69
11.1 Overview 69
11.2 Trends in Corporate Strategy 69
11.3 Company Profiles 69
11.3.1 Aesculap 69
11.3.2 Alphatec Spine 72
11.3.3 Amedica Corporation 75
11.3.4 Medtronic Spinal and Biologics 77
11.3.5 DePuy Spine 80
11.3.6 Globus Medical 83
11.3.7 K2M 86
11.3.8 Biomet 89
11.3.9 Stryker 92
11.3.10 Zimmer 95
11.3.11 Nuvasive 99
11.3.12 Orthofix 102
11.3.13 Integra LifeSciences 105
12 Market Outlook 109
12.1 Company Market Share 109
12.2 By Geography 110
12.2.1 France 110
12.2.2 Germany 112
12.2.3 Italy 113
12.2.4 Spain 115
12.2.5 UK 116
13 Appendix 118
13.1 Bibliography 118
13.2 Abbreviations 128
13.3 Report Methodology 129
13.3.1 Overview 129
13.3.2 Coverage 129
13.3.3 Primary Research 129
13.3.4 Secondary Research 130
13.3.5 Forecasting Methodology 131
13.4 Key Opinion Leaders Included in this Study 132
13.5 About the Authors 133
13.5.1 Joseph A. Gregory, Analyst, Surgical Devices 133
13.5.2 Derek Archila, MBA, Director of Research and Analysis, Medical Devices 133
13.6 Global Head of Healthcare 134
13.6.1 Bonnie Bain, Ph.D., Global Head of Healthcare 134
13.7 About MediPoint 135
13.8 About GlobalData 135
13.9 Disclaimer 135

1.1 List of Tables

Table 1: Indications for Lumbar Spinal Fusion 16
Table 2: Adoption of Spinal Fusion and Spinal Non-Fusion, 5EU, 2013 and 2020 20
Table 3: Spinal Plating Systems CAGR, 5EU, Based on 2013 and 2020 Procedure Volumes 21
Table 4: Interbody Cages CAGR, 5EU, Based on 2013 and 2020 Procedure Volumes 23
Table 5: Pedicle Screw Systems CAGR, 5EU, Based on 2013 and 2020 Procedure Volumes 25
Table 6: Adoption of Spinal Implants for Cervical Fusion Procedures, 5EU, 2013 29
Table 7: Adoption of Spinal Implants for Thoracolumbar Fusion Procedures, 5EU, 2013 29
Table 8: Mergers and Acquisitions, 2010-2014 34
Table 9: Population Aged 60 Years Old or Over, 1950-2050 (in millions) (percentage in older ages) 51
Table 10: Overall Perceived Advantages of Minimally Invasive Surgery Techniques, 2007 57
Table 11: Overall Perceived Limitations of Minimally Invasive Surgery Techniques, 2007 57
Table 12: Company Portfolio - Aesculap 70
Table 13: Product Portfolio - Aesculap 71
Table 14: Company Portfolio - Alphatec Spine 73
Table 15: Product Portfolio - Alphatec Spine 74
Table 16: Company Portfolio - Amedica 76
Table 17: Product Portfolio - Amedica 77
Table 18: Company Portfolio - Medtronic Spinal and Biologics 78
Table 19: Product Portfolio - Medtronic Spinal and Biologics 79
Table 20: Company Portfolio - DePuy Spine 81
Table 21: Product Portfolio - DePuy Spine 82
Table 22: Company Portfolio - Globus Medical 84
Table 23: Product Portfolio - Globus Medical 85
Table 24: Company Portfolio - K2M 87
Table 25: Product Portfolio - K2M 88
Table 26: Company Portfolio - Biomet 90
Table 27: Product Portfolio - Biomet 91
Table 28: Company Portfolio - Stryker 93
Table 29: Product Portfolio - Stryker 94
Table 30: Company Portfolio - Zimmer 97
Table 31: Product Portfolio - Zimmer 98
Table 32: Company Portfolio - Nuvasive 100
Table 33: Product Portfolio - Nuvasive 101
Table 34: Company Portfolio - Orthofix 103
Table 35: Product Portfolio - Orthofix 104
Table 36: Company Portfolio - Integra LifeSciences 106
Table 37: Product Portfolio - Integra LifeSciences 107
Table 38: Spinal Surgery, 5EU Company Market Share, 2012 109
Table 39: France Spinal Fusion Sales ($m) Forecast, 2011-2020 111
Table 40: Germany Spinal Fusion Sales ($m) Forecast, 2011-2020 112
Table 41: Italy Spinal Fusion Sales ($m) Forecast, 2011-2020 114
Table 42: Spain Spinal Fusion Sales ($m) Forecast, 2011-2020 115
Table 43: UK Spinal Fusion Sales ($m) Forecast, 2011-2020 117

1.2 List of Figures

Figure 1: Spinal Plating Procedure Volumes, 5EU, 2011-2020 22
Figure 2: Interbody Cages Procedure Volumes, 5EU, 2011-2020 24
Figure 3: Pedicle Screw Systems Procedure Volumes, 5EU, 2011-2020 26
Figure 4: Spinal Fusion Procedure Volumes, US, 2002-2011 38
Figure 5: Spinal Surgery, 5EU Company Market Share, 2012 110
Figure 6: France Spinal Fusion Sales ($m) Forecast, 2011-2020 111
Figure 7: Germany Spinal Fusion Sales ($m) Forecast, 2011-2020 113
Figure 8: Italy Spinal Fusion Sales ($m) Forecast, 2011-2020 114
Figure 9: Spain Spinal Fusion Sales ($m) Forecast, 2011-2020 116
Figure 10: UK Spinal Fusion Sales ($m) Forecast, 2011-2020 117

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

  • $ 33500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 33-country survey from VPGMarketResearch.com contains over 900 pages, 380 tables and provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.